Geneseeq to Showcase Twelve Studies at 2024 American Association for Cancer Research (AACR) Annual Meeting

[Toronto, March 6, 2024] – The AACR Annual Meeting is one of the most significant gatherings in the field of oncology, attracting leading scientists, clinicians, and industry professionals worldwide. This year’s AACR 2024, taking place from April 5th to 10th in San Diego, provides a platform for Geneseeq to showcase its latest advancements in cancer genomics and personalized medicine

Geneseeq’s mini-oral presentations will release the most recent results from multi-cancer early detection(MCED) case-control study and the “Jinling cohort,” a 15,000-participant perspective MCED cohort study. In addition to the mini-oral presentations, Geneseeq will present ten posters featuring a diverse range of studies covering various aspects of minimal residual disease (MRD), cancer genomics and biomarker identification.